Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

2020 Updates on Frontline AML: Does Midostaurin+Chemo Reduce the Risk of Death in FLT3-Mutated Disease? Can We Prolong OS and Achieve CR With CPX-351? Is There a Way to Avoid Apoptosis With Ven+FLAI?

0 views
December 11, 2020
Comments 0
Login to view comments. Click here to Login